论文信息 - Biopharmaceutical benchmarks

Biopharmaceutical benchmarks

Less than 20 years after the first biopharmaceutical, insulin, was approved, a new generation of products is superseding replacement proteins and enzyme therapies in biotechnology's pipeline.

Gary Walsh | G. Walsh

[1] W. Blackstock,et al. Proteomics: quantitative and physical mapping of cellular proteins. , 1999, Trends in biotechnology.

[2] Wang,et al. Proteomics in drug discovery. , 1999, Drug discovery today.

[3] Dyer,et al. Functional genomics: from genes to new therapies. , 1999, Drug discovery today.

[4] G. Zweiger,et al. Knowledge discovery in gene-expression-microarray data: mining the information output of the genome. , 1999, Trends in biotechnology.

[5] A. Colman. Dolly, Polly and other 'ollys': likely impact of cloning technology on biomedical uses of livestock. , 1999, Genetic analysis : biomolecular engineering.